πŸ‡ΊπŸ‡Έ FDA
Patent

US 10478409

Pharmaceutical compositions

granted A61KA61K31/00A61K31/165

Quick answer

US patent 10478409 (Pharmaceutical compositions) held by KalVista Pharmaceuticals Limited expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KalVista Pharmaceuticals Limited
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/00, A61K31/165, A61K31/166, A61K31/18